GlobeNewswire by notified

Iværksættelse af aktietilbagekøbsprogram

Del

Nasdaq Copenhagen
London Stock Exchange        
Euronext Dublin
Øvrige interessenter

Dato    1. februar 2023

Iværksættelse af aktietilbagekøbsprogram

Bankens bestyrelse har i dag besluttet at iværksætte et aktietilbagekøbsprogram på i alt 385 mio. kroner med det formål at annullere disse på en senere generalforsamling.

Aktietilbagekøbsprogrammet afvikles med baggrund i den generelle bemyndigelse, som bankens bestyrelse fik fra den ordinære generalforsamling afholdt den 2. marts 2022, til at lade banken erhverve egne aktier.

Aktietilbagekøbsprogrammet løber i perioden fra og med den 2. februar 2023 og til og med den 27. juli 2023 under forudsætning af den kommende ordinære generalforsamlings (til afholdelse den 1. marts 2023) fornyede bemyndigelse til bestyrelsen til at lade banken erhverve egne aktier.

I perioden vil banken tilbagekøbe egne aktier for op til maksimalt 385 mio. kroner, dog vil der maksimalt kunne erhverves 1.000.000 stk. aktier under aktietilbagekøbsprogrammet.

Aktietilbagekøbsprogrammet gennemføres i henhold til EU-Kommissionens forordning nr. 596/2014 af 16. april 2014 og EU-Kommissionens delegerede forordning nr. 2016/1052 af 8. marts 2016, der tilsammen udgør ”Safe Harbour”-reguleringen.

Banken kan til enhver tid suspendere eller stoppe aktietilbagekøbet. Dette vil i givet fald blive meddelt i en selskabsmeddelelse.

Betingelserne for aktietilbagekøbsprogrammet er følgende:

  • Formålet med aktietilbagekøbet er tilpasning af bankens kapitalstruktur.
  • Ringkjøbing Landbobank har antaget Danske Bank som lead manager for aktietilbagekøbs-programmet. Danske Bank vil uafhængigt af og uden indflydelse fra Ringkjøbing Landbobank træffe sine handelsbeslutninger og eksekvere aktieopkøb inden for de offentliggjorte rammer.
  • Det maksimale vederlag, som Ringkjøbing Landbobank kan betale for aktier tilbagekøbt under programmet, er 385 mio. kroner, dog således der maksimalt kan erhverves 1.000.000 stk. aktier under programmet.
  • Tilbagekøbet må ikke ske til en aktiekurs, der overstiger den højeste af (i) aktiekursen på den senest uafhængige handel eller (ii) det højeste uafhængige købers bud i markedet på Nasdaq Copenhagen på handelstidspunktet.
  • Det maksimale antal aktier, der kan opkøbes på én enkelt handelsdag, vil svare til 25% af den gennemsnitlige daglige aktiehandelsvolumen i de 20 forudgående handelsdage på Nasdaq Copenhagen.
  • Ringkjøbing Landbobank vil ugentligt offentliggøre en separat meddelelse til Nasdaq Copenhagen og annoncere antallet af tilbagekøbte aktier og deres værdi samt vedlægge detaljeret information om de enkelte handler.


Venlig hilsen

Ringkjøbing Landbobank

John Fisker
Adm. direktør

Vedhæftet fil

For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.
For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.

Information om GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeddelelser fra GlobeNewswire by notified

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra GlobeNewswire by notified

Wood Mackenzie appoints new Chief Financial Officer27.3.2023 18:22:05 CEST | Press release

Simon Crowe, formerly of ERM, brings sustainability and energy industry experience LONDON and HOUSTON and SINGAPORE, March 27, 2023 (GLOBE NEWSWIRE) -- Wood Mackenzie, a portfolio company of Veritas Capital, has appointed Simon Crowe to its global executive leadership team as Chief Financial Officer (CFO), effective 27th March. Simon brings a wealth of experience in private and public companies in the US, Europe and Asia. He joins Wood Mackenzie after nearly five years as CFO of ERM, the world’s largest Sustainability and Environmental Consultancy where he played a key role in their rapid growth, diversification, and successful investment from KKR. Commenting on Simon’s appointment, Mark Brinin, CEO of Wood Mackenzie said: “Simon is a commercially minded CFO, with a breadth of international experience, having worked with private equity backed ERM and companies listed on New York, London and European stock exchanges. He has strong financial management and strategic leadership skills. Si

BBS-Bioactive Bone Substitutes – Inside information: The final report of the second audit received from the Notified Body, CE marking process may continue and CE marking approval continues to be expected during 202327.3.2023 18:20:00 CEST | Press release

BBS-Bioactive Bone Substitutes, Company announcement, Insider information, 27 March 2023 at 7:20 p.m. EEST BBS-Bioactive Bone Substitutes – Inside information: The final report of the second audit received from the Notified Body, CE marking process may continue and CE marking approval continues to be expected during 2023 The Notified Body has completed its second audit. The audit was carried out during 10-13 March 2023, the audit report was received on 20 March 2023, and today on 27 March 2023 the last meeting related to the audit was held with the authorities. The second audit was related to the approval process of BBS-Bone Substitutes Plc’s quality system, which is part of the CE marking process for the company's first product (ARTEBONE® Paste -bone filler). During the second audit, the Notified Body inspected more closely detailed product documentation and the production processes. According to the final audit report, certain additional measures are required from the company, and th

Ilkka Oyj – Acquisition of own shares on 27 March 202327.3.2023 18:00:00 CEST | Press release

ILKKA OYJ, STOCK EXCHANGE RELEASE, 27 March 2023 at 19:00 EET IlkkaOyj – Acquisition of own shares on 27 March 2023 At Nasdaq Helsinki Ltd: Date27 March 2023Exchange transactionBuyShare trading codeILKKA2Amount, shares 453Average price/share, EUR3.8044Total cost, EUR1,723.39 The company holds a total of 82,890 of its own shares (ILKKA2) including the shares acquired on 27 March 2023. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 www.ilkka.com Attachment Ilkka buyback 27.3.2023

Mendus announces request for conversion of convertible bonds by Negma Group27.3.2023 18:00:00 CEST | Press release

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group (“Negma”) has by notice to Mendus requested the conversion of convertible bonds that have been issued to Negma in accordance with the financing agreement announced by Mendus through press releases on 26 August and 26 October 2022. Negma has requested conversion of six (6) convertible bonds issued on 3 January 2023, corresponding to SEK 150,000 of the convertible loan amounting to a total of SEK 5,425,000, into 127,118 shares. Upon registration at the Swedish Companies Registration Office, Mendus’ total share capital will amount to SEK 10,071,926.2 and the total number of shares and votes will amount to 201,438,524. The conversion price per share is SEK 1.18, equivalent to 92% of the second lowest closing volume weighted average share price (VWAP) of the 10 consecutive trading days preceding the issuance of conversion request by Negma.

Mendus tillkännager begäran från Negma Group om konvertering av konvertibla skuldebrev27.3.2023 18:00:00 CEST | Pressemelding

Mendus AB (“Mendus” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på immunterapier mot tumöråterfall, tillkännager idag att Negma Group (”Negma”) genom meddelande till Mendus har begärt konvertering av konvertibla skuldebrev som utfärdats till Negma i enlighet med det finansieringsavtal som Mendus tillkännagivit genom pressmeddelanden den 26 augusti och 26 oktober 2022. Negma har begärt konvertering av sex (6) konvertibla skuldebrev som emitterades den 3 januari 2023, motsvarande 150 000 kronor av det konvertibla lånet som uppgår till totalt 5 425 000 kronor, till 127 118 aktier. Efter registrering hos Bolagsverket kommer Mendus totala aktiekapital att uppgå till 10 071 926,2 kronor och det totala antalet aktier och röster kommer att uppgå till 201 438 524. Konverteringspriset per aktie är 1,18 kronor, motsvarande 92% av den näst lägsta dagliga volymvägda genomsnittliga aktiekursen (VWAP) under de 10 på varandra följande handelsdagarna före konverteringsbegäran från Negma. För ytt